Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chemotherapy Market Size Changed, over the years?

In the past few years, there has been a substantial growth in the market size of chemotherapy. It is anticipated to escalate from $34 billion in 2024 to $37.78 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.1%. The remarkable growth during the historical period can be ascribed to factors such as the rising incidence of cancer, the progress in the detection of cancer, the creation of innovative drugs, active clinical trials, ease of access to healthcare, and promotional campaigns for awareness.

How Much Will the Chemotherapy Market Be Worth in 2029?

Anticipations point towards a significant expansion of the chemotherapy market in the coming years. With a compound annual growth rate (CAGR) of 13.3%, the market is projected to escalate to $62.22 billion by 2029. The projected growth within this period can be traced to factors such as the incorporation of immunotherapy, the adoption of biosimilars, burgeoning markets, genomic profiling, advancements in supportive care and regulatory facilitation. Looming trends within this forecast period encompasses digital health solutions, personalized medicine, sustained research in oncology, the integration of artificial intelligence (ai), advancements in nanotechnology and the administration of chemotherapy at home.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9219&type=smp

Which is the Largest Company in the Chemotherapy Market?

Major companies operating in the chemotherapy market include GlaxoSmithKline plc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Novartis AG, Pfizer Inc., Merck & Co Inc., Sanofi SA, Celgene Corporation, Bristol-Myers Squibb Company, Amgen Inc., Bayer AG, Almatic Pharma LLC, AstraZeneca Pharmaceuticals, Astellas Pharma Inc., Puma Biotechnology Inc., Clovis Oncology Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc., Mylan NV, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Gilead Sciences Inc., Biogen Inc., Eisai Co. Ltd., Ipsen SA, Spectrum Pharmaceuticals Inc., Seattle Genetics Inc., Exelixis Inc., Karyopharm Therapeutics Inc., Incyte Corporation, Agios Pharmaceuticals Inc., Epizyme Inc., Blueprint Medicines Corporation, Array BioPharma Inc., BeiGene Ltd., Halozyme Therapeutics Inc., MacroGenics Inc., Immunomedics Inc., TG Therapeutics Inc., Verastem Inc.

What Are the Main Market Drivers in the Chemotherapy Industry?

The escalation in cancer incidences is anticipated to stimulate the expansion of the chemotherapy market. Cancer is a condition where some body cells proliferate uncontrollably and invade other areas. Chemotherapy employs potent chemicals, either singly or in a mix, to treat cancer by exterminating rapidly proliferating cancer cells. Moreover, the rise in cancer incidences will heighten the need for chemotherapy. For instance, the American Cancer Society Inc., a non-profit health organization based in the US, predicts that by 2023, there will be 1.9 million new cancer diagnoses in the US, a rise from the 1.8 million new cases diagnosed in 2020. There are projections of 609,820 cancer-related fatalities in the US in 2023, whilst 606,520 cancer deaths were projected for 2020. Thus, the escalating incidences of cancer are fueling the growth of the chemotherapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9219&type=smp

How Is the Chemotherapy Market Segments Structured?

The chemotherapy market covered in this report is segmented –

1) By Product Type: Pump, Cannula, Catheter, Other Product Types

2) By Service: Blood Cancer, Throat Cancer, Lung Cancer, Ovarian Cancer, Stomach Cancer

3) By Drugs: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Other Drugs

4) By Route Of Administration: Oral, Intravenous

5) By End User: Hospitals, Research Institutes, Other End Users

Subsegments:

1) By Pump: Infusion Pumps, Portable Pumps, Ambulatory Pumps

2) By Cannula: Peripheral Cannulas, Central Venous Catheters, Implantable Ports

3) By Catheter: Chemotherapy Catheters, PICC Lines

4) By Other Product Types: Safety Devices, IV Sets, Administration Sets

What Strategic Trends Are Transforming the Chemotherapy Market?

Leading corporations in the chemotherapy market are concentrating on bringing forth innovative products such as chemotherapy infusion pumps to solidify their position. These infusion pumps serve as a conduit for chemo drugs directly into the patient’s bloodstream via an IV line. It aids in the regulation of chemotherapy delivery in a controlled fashion, permitting a consistent, gradual introduction of drugs into the body. A case in point, in March 2022, Shanghai MicroPort Lifesciences Co. Ltd., a medical technology developer and manufacturer based in China, got the green light from the National Medical Products Administration (NMPA) of China to market its AutoEx Chemotherapy Infusion Pump. The pump is a design for the continuous or sporadic infusion of chemotherapy treatments for patients battling malignancies. Its function is to uphold the optimum drug concentration in the blood, thereby boosting the efficacy of the cancer treatment while minimizing side effects. The infusion pump boasts of a dual CPU control system and dual power supply, allowing the precise delivery of drugs and improving the patient’s comfort and safety during chemotherapy treatments.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chemotherapy-global-market-report

Which Global Regions Offer the Highest Growth in the Chemotherapy Market?

North America was the largest region in the chemotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the chemotherapy market report during the forecast period. The regions covered in the chemotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9219

This Report Delivers Insight On:

1. How big is the chemotherapy market, and how is it changing globally?

2. Who are the major companies in the chemotherapy market, and how are they performing?

3. What are the key opportunities and risks in the chemotherapy market right now?

4. Which products or customer segments are growing the most in the chemotherapy market?

5. What factors are helping or slowing down the growth of the chemotherapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model